Explore All 2031 Add-on Acquisition Media Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | June 1, 1999 |
| Target | Sygma S.A. |
| Sector | Media |
| Buyer(s) | Corbis |
| Sellers(s) | Perseus |
| Deal Type | Add-on Acquisition |
FILTER BY
Corbis Corp. is a digital content and worldwide entertainment rights company.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Media | 1 of 1 |
| Type: Add-on Acquisition | 1 of 1 |
| Country: United States | 1 of 1 |
| Year: 1999 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-07-10 |
eMotion
Seattle, Washington, United States eMotion LLC is a provider of softwae solutions and company serves more than 70 marketing-department customers, including some of the largest Fortune 500 companies. |
Sell | $5M |
| Category | Merchant Bank |
|---|---|
| Founded | 1995 |
| PE ASSETS | 2.0B USD |
| Size | Large |
| Type | Sector Agnostic |
Perseus is a private equity firm focused on middle-market buyouts, recapitalizations, and growth equity investments. Perseus looks businesses operating with proven management, strong brands, and 'powerful intellectual property'. Sectors of interest include biotechnology, medical devices, branded consumer products, business services, information technology, communications, and energy/environmental service companies. Perseus was formed in 1995 and maintains offices in Washington DC, New York City, and Munich.
| Deal Context for Seller | # |
|---|---|
| Overall | 4 of 31 |
| Sector: Media | 1 of 1 |
| Type: Add-on Acquisition | 3 of 22 |
| Country: United States | 4 of 26 |
| Year: 1999 | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 1999-05-20 |
Live Picture
Campbell, California, United States Live Picture, Inc. is a developer and marketer of digital photo-real imaging servers and tools for the enterprise and consumer markets. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 1999-12-22 |
LeukoSite
Cambridge, Massachusetts, United States LeukoSite, Inc. is a biotechnology company developing proprietary monoclonal antibody and small molecule drugs to treat patients with cancer and inflammatory, autoimmune and viral diseases. |
Sell | - |
